Finally, a prognostic signature based on nine ARGs (HSP90AA1, NFKB2, PLAU, PTK2, RECQL4, CLU, JAK2, MAP3K5, and S100B) were built based on 1046 patients with BC in the training set. Here, CLU is linked to breast cancer.